How to Store Peptides — and How Long They Actually Last

A peptide has two completely different shelf lives: one as dry powder, one in solution. Knowing which clock you are on is most of the job.

Two shelf lives, not one

Most storage confusion comes from treating a vial as a single object with a single expiry. It is not. The same peptide has two stability profiles, and they are separated by orders of magnitude.

Lyophilized (freeze-dried) powder is the durable state. Bachem, one of the larger contract peptide manufacturers, advises long-term storage of lyophilized peptides in a tightly closed container below −15 °C, with lower temperatures preferred, and notes that refrigeration at 4 °C is suitable for shorter periods. At freezer temperatures, well-made powder is generally counted in years.

Reconstituted peptide in solution is the fragile state. The same guidance advises against long-term storage of peptide solutions, especially where the peptide contains Asn, Gln, Cys, Met or Trp, and says frozen solutions may be kept only for a few weeks. Everything that breaks a peptide down needs water to work. Add water and you start the clock.

That is the whole model. Powder: slow. Solution: fast. If you take one thing from this page, take that.

What actually degrades a peptide in solution

Four processes do most of the damage, and knowing them explains every storage rule that follows.

• Hydrolysis — water cleaves the peptide backbone. Acid- and base-catalyzed, and strongly pH dependent. Aspartate-proline sites are notoriously weak points.
• Deamidation — asparagine and glutamine residues convert to aspartate and glutamate — and, via the same cyclic imide intermediate, to isoaspartate, usually the predominant product. The rate depends heavily on the neighbouring residue; a glycine next to an asparagine speeds it up considerably.
• Oxidation — methionine, cysteine and tryptophan are the main targets. Trace metal ions, dissolved oxygen and light all accelerate it.
• Aggregation — molecules clump. Sometimes triggered by one of the above; oxidation followed by aggregation is a common sequence.

All four are chemical reactions, and chemical reactions slow down when you cool them. As a rough rule of thumb, reaction rates fall by roughly half for every 10 °C you drop. That is not a formula you can use to predict a shelf life, but it is the reason a fridge buys you weeks and a bench does not.

It also explains why the dry state is so much more forgiving. Remove the water and hydrolysis has no reagent, dissolved oxygen is largely gone, and molecular mobility — the thing aggregation needs — is close to frozen in place.

Temperature, by state

Unmixed powder

Refrigerator (2–8 °C) is suitable for short-term storage. Freezer is better for anything you are holding long-term. Freezer is better for anything you are holding long-term. Keep the vial sealed and dry: peptides containing charged residues such as Asp, Glu, Lys, Arg or His readily pull moisture out of the air, and absorbed moisture both dilutes the stated content and reduces stability. Separately, Bachem flags peptides containing Asn, Gln, Met, Cys or Trp as having inherently limited shelf lives — sequence, not just storage, sets the ceiling.

One handling detail that gets skipped: let a cold vial come up to room temperature before you open or puncture it. Opening a cold vial in a warm room condenses water onto the powder. If you are storing powder frozen, this matters more, not less.

Mixed solution

Refrigerate. Do not freeze a reconstituted vial. Freezing sounds protective and is not, because you rarely freeze once — you freeze, thaw to draw a dose, and refreeze. Each cycle forms ice crystals that concentrate everything in the shrinking unfrozen fraction, shifting local pH and ionic strength, and creates new ice-liquid interfaces — and, on thawing, air-liquid ones — that promote aggregation. Laboratories that do freeze peptide solutions solve this by aliquoting into single-use portions at the moment of reconstitution, so no vial is ever thawed twice. A multi-dose vial you draw from repeatedly is the opposite of that.

For a working vial you inject from, the fridge is the answer, and the limit is usually microbiological rather than chemical — see below.

Where the 28-day rule comes from

The number people quote for a reconstituted vial is 28 days, and it is worth knowing what it is and is not.

It comes from beyond-use dating for compounded sterile preparations. USP General Chapter <797> assigns a 28-day beyond-use date to a multiple-dose container after it is first entered or punctured, unless the manufacturer specifies otherwise, on the basis that the antimicrobial preservative in such a container is only validated to hold for that long. Bacteriostatic water for injection is exactly that kind of container: sterile water with 0.9% (9 mg/mL) benzyl alcohol added as a bacteriostatic preservative, supplied in a multiple-dose vial for repeated withdrawals. This matters more than it sounds: the 28-day window belongs to the preservative, not to the peptide. If a vial is reconstituted with preservative-free Sterile Water for Injection instead, there is no antimicrobial protection at all, the 28-day convention does not apply, and the accepted window collapses to hours — such a preparation is treated as single-use. Note that the diluent's own FDA label does not print "28 days" — the number is a compounding-standard convention that has become common practice, not a line on the bottle.

Two important limits. First, 28 days is a sterility ceiling, not a potency guarantee. A peptide can lose meaningful purity well inside 28 days, and a stable one can be chemically intact well past it. Second, a beyond-use date never extends past the manufacturer's own expiry.

Light

Light protection is not superstition. The residues that absorb in the near-UV — tryptophan, tyrosine and cystine — are the entry point for photo-oxidation, and their oxidation can cascade into secondary damage at methionine and histidine. Tryptophan photo-oxidation yields kynurenine and related products; methionine yields methionine sulfoxide. Ambient room and lab lighting, not just direct sun, is enough to drive this in therapeutic protein and peptide formulations.

The commercial analogue is instructive. Tirzepatide, an FDA-approved peptide sold as a ready-made solution, is labeled for refrigerated storage at 2–8 °C, must not be frozen, carries a limited room-temperature window (21 days on the current U.S. label), and is directed to be kept in its original carton specifically to protect it from light. That is a manufacturer with stability data choosing an opaque box. Amber vials, the original carton, or simply the back of a fridge shelf all accomplish the same thing.

Travel, shipping and the cold chain

Lyophilized powder tolerates ambient transit. Peptide manufacturers ship products at ambient temperature as standard practice, with storage conditions stated on the label for after arrival. A few days between 20 and 30 °C in a dry, sealed vial is a small dent in a multi-year clock. If a shipment sat in a warm truck for a week, that is not automatically a ruined product — though sustained heat is a different question, and prolonged exposure well outside the labelled storage range is a reason to ask the vendor rather than to guess, and a vendor's certificate of analysis tells you what the material was at the point of testing, not what a courier did to it.

Reconstituted vials are the ones that need a cold chain. For a flight, that means an insulated pouch with a cold pack. In the United States, medically necessary liquids and cooling packs are permitted through security in excess of the standard liquid limit if you declare them at the checkpoint; check your own jurisdiction's rules before you fly. Do not check it — cargo holds swing hot and cold, and you lose the vial if the bag does.

For long trips, travelling with unmixed powder and reconstituting on arrival removes the problem entirely. Our reconstitution guide covers the mixing step itself.

What degradation looks like — and what it doesn't

There are visible signs worth acting on:

• Cloudiness or haze in what should be a clear solution.
• Visible particulates — floaters, strands, crystals.
• Discoloration. Manufacturer labels are explicit about this: the tirzepatide label instructs the user to inspect visually before use, expects a clear, colorless to slightly yellow solution, and says not to use it if particulate matter or discoloration is seen.
• A collapsed or melted cake. A good lyophilized cake is a uniform plug that holds its shape. If it has slumped, gone glassy, or shrunk to a film at the bottom, that indicates moisture ingress or heat exposure — and moisture in a dried cake lowers the glass transition temperature, which is what kept the peptide immobilized in the first place.

Now the part that matters more. A peptide can degrade substantially with no visible change at all. Deamidation converts one residue to another and produces a solution that looks identical. Oxidation of a single methionine is invisible. Backbone hydrolysis produces fragments that stay dissolved. These are detected by chromatography, not by eyes.

So treat appearance as a floor, not a guarantee. Cloudy means stop. Clear does not mean fine.

The checklist

1. Store unmixed powder cold and sealed — fridge for months, freezer for longer. Keep it dry.
2. Let a cold vial reach room temperature before opening or puncturing it.
3. Refrigerate the reconstituted vial you draw from, and never refreeze a vial once thawed. Freezing is only appropriate for single-use aliquots portioned at the moment of reconstitution.
4. Keep vials in the dark: original carton, amber vial, or back of the fridge.
5. Write the first-puncture date on the vial. Apply your discard convention from that date, not from when you received it.
6. Travel with powder where you can. If you must travel with solution, insulated pouch, carry-on, declared at security.
7. Inspect every draw. Cloudiness, particulates, discoloration or a collapsed cake mean stop — and a clear vial still isn't proof of potency.

Frequently asked

Sources

• Bachem — Handling and Storage Guidelines for Peptides — 2026
• Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review — 2023
• Sigma-Aldrich — Peptide Stability and Potential Degradation Pathways — 2026
• Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide — 1990
• Photo-Oxidation of Therapeutic Protein Formulations: From Radical Formation to Analytical Techniques — 2022
• USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations (current official revision) — 2023
• DailyMed — Bacteriostatic Water for Injection, USP (label) — 2026
• DailyMed — MOUNJARO (tirzepatide) injection, solution (label) — 2026
• Humidity induced collapse in freeze dried cakes: A direct visualization study using DVS — 2018

For research peptide users tracking their own protocol. Not medical advice. Peptides referenced here are research chemicals, not FDA-approved drugs. Consult a qualified clinician for medical decisions.